MAP2 and nasopharyngeal carcinoma: We identified 18 unique MAP2 phosphopeptides in our samples (Table S2), confirmed by manual sequencing of MS2 spectra, 8 of which were significantly altered (q < 0.05) in MAP2-IRLOW Sz subjects relative to NPC subjects (Table S2).